Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-19-001297
Filing Date
2019-02-15
Accepted
2019-02-15 14:36:30
Documents
1
Group Members
AIGH CAPITAL MANAGEMENT, LLCAIGH INVESTMENT PARTNERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 AMENDED SC 13G mlnd-sc13ga_123118.htm SC 13G/A 72768
  Complete submission text file 0001387131-19-001297.txt   74183
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G/A

Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87213 | Film No.: 19611019
SIC: 2834 Pharmaceutical Preparations